Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

IV Metoprolol Dosing for NPO Patients to Prevent Rebound Tachycardia

Standard IV Dosing Protocol

  • The American Heart Association recommends administering metoprolol as 5 mg IV boluses over 1-2 minutes, repeated every 5 minutes as tolerated, up to a maximum total dose of 15 mg (three 5 mg doses), with careful monitoring of heart rate and blood pressure between each dose 1, 2
  • The initial dose of metoprolol is 5 mg IV administered slowly over 1-2 minutes, with repeat dosing of 5 mg boluses every 5 minutes as needed 1, 2
  • The maximum total dose of metoprolol is 15 mg (three separate 5 mg boluses) 1, 2

Critical Pre-Administration Assessment

  • Patients with heart failure signs, such as rales, low output state, or decompensated heart failure, should be excluded from receiving IV metoprolol 1, 2, 3
  • Hemodynamic instability, defined as systolic BP <100-120 mmHg, is a contraindication for IV metoprolol 2, 3
  • Bradycardia, defined as heart rate <60 bpm or >110 bpm, is a contraindication for IV metoprolol 2
  • Conduction abnormalities, such as PR interval >0.24 seconds, second or third-degree AV block, are contraindications for IV metoprolol 1, 2, 3
  • Active asthma or reactive airway disease are contraindications for IV metoprolol 1, 2, 3

Required Monitoring During Administration

  • Continuous ECG monitoring is mandatory throughout IV metoprolol administration 2
  • Blood pressure checks should be performed before each dose and frequently thereafter 2, 3
  • Heart rate monitoring should be continuous 2
  • Auscultation for rales (pulmonary congestion) and bronchospasm should be performed after each dose 1, 2, 3

Alternative for High-Risk Patients

  • For high-risk patients, esmolol may be considered instead of metoprolol, with a loading dose of 500 mcg/kg over 1 minute and a maintenance infusion of 50-300 mcg/kg/min 1, 2
  • The advantage of esmolol is its ultra-short half-life (2-9 minutes), which allows for rapid titration and quick reversal if adverse effects occur 1